prostate cancer awareness month
DESCRIPTION
September is National Prostate Cancer Awareness Month, and Philadelphia CyberKnife encourages men seeking prostate cancer treatment to educate themselves on the range of options available to treat the disease.TRANSCRIPT
2010 West Chester Pike Suite 115 Havertown, PA 19083 (610) 446-‐6850 www.phillycyberknife.com
September is Prostate Cancer Awareness Month
Did you know?
A Service of Delaware County Memorial Hospital
2010 West Chester Pike Suite 115 Havertown, PA 19083 (610) 446-‐6850 www.phillycyberknife.com
Did you know?
Quick stats: • 1 in 6 men will be diagnosed with prostate
cancer during his life:me.
• Prostate cancer occurs mainly in older men. Nearly two-‐thirds of cases are diagnosed in men aged 65 or above, and it is rare before age 40. The average age at the :me of diagnosis is about 67.
• More than 2.5 million men in the United
States who have been diagnosed with prostate cancer at some point are s:ll alive today, thanks to advancements in treatment.
The American Cancer Society esFmates 241,740 new prostate cancer diagnoses in 2012.
2010 West Chester Pike Suite 115 Havertown, PA 19083 (610) 446-‐6850 www.phillycyberknife.com
Did you know?
How it works: • CyberKnife treats prostate cancer with a procedure called
stereotac:c body radia:on therapy, a noninvasive method of trea:ng tumors with precisely targeted high-‐dose radia:on. The result is greatly increased accuracy that spares healthy Fssue.
• Prior to treatment, small metal :ssue markers known as fiducials
are implanted in the prostate to help the CyberKnife pinpoint the tumor loca:on throughout each treatment, ensuring the radiaFon beams delivered during treatment are always locked on the tumor.
• Pa:ents are then scheduled for no more than five CyberKnife
treatments. Each treatment takes about 30 -‐ 40 minutes, and paFents can return to their normal rouFnes following each procedure.
• In recent years, CyberKnife has gained awareness among prostate cancer pa:ents in par:cular. Many men are drawn to the convenience of shorter treatment and fewer side effects.
CyberKnife can noninvasively treat prostate cancer in five or fewer treatment sessions.
Our Center
Medical Director: Dr. Luther Brady Associate Medical Director: Dr. John Lamond DCMH Chief of Radiation Oncology: Dr. Rachelle Lanicano Chief Medical Physicist: Jun Yang, Ph.D., DABR CyberKnife Nurse: Michael Good
Other Resources
2010 West Chester Pike Suite 115 Havertown, PA 19083 (610) 446-‐6850 www.phillycyberknife.com
Philadelphia CyberKnife established the first CyberKnife program in the greater Philadelphia area and has one of the most experienced CyberKnife clinical teams in the region. The center is actively engaged in research with team members publishing several scientific papers on the treatment of prostate cancer. Philadelphia CyberKnife is a service of Delaware County Memorial Hospital, a member of the Crozer-Keystone Health System.